Friday, July 7, 2017

News provided by U.S. Food and Drug Administration

July 7, 2017

The U.S. Food and Drug Administration today approved Endari (L-glutamine oral powder) for patients age five years and older with sickle cell disease to reduce severe complications associated with the blood disorder.